Thursday, January 11, 2024 12:34:02 PM
LOS GATOS, CA - Atomera Incorporated (NASDAQ:ATOM), a company specializing in semiconductor materials and licensing technology, announced today an increase in its fourth-quarter 2023 revenue forecast to approximately $500,000. This revised figure surpasses the company's previous revenue guidance, which ranged from $300,000 to $350,000.
The upward revision comes after Atomera achieved a key revenue milestone in late December under its first commercial license agreement. This milestone was reached when the customer approved the MST (Mears Silicon Technology™) process following the successful validation of MST film deposition on an Epi tool within their facility. This acceptance indicates that the customer can now independently manufacture wafers with MST, which is expected to expedite development and shorten the timeline to mass production and subsequent royalties for Atomera.
Scott Bibaud, President and CEO of Atomera, stated, "Our first commercial licensee was able to complete installation of our technology and independently validate MST film quality just weeks after receiving our recipe." He noted that this development brings the licensee closer to the commercial distribution of MST-enabled products and demonstrates Atomera's role in enhancing transistor performance and advancing the semiconductor industry.
Recent ATOM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 08:02:10 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/11/2024 08:01:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/08/2024 09:02:05 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/08/2024 09:01:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 12:00:19 AM
- Media Alert: Atomera to Present Joint Paper with Soitec and San Jose State University on Advanced RF Technologies at 8th IEEE Electronic Devices Technology and Manufacturing (EDTM) Conference 2024 • Business Wire • 02/22/2024 10:05:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/15/2024 09:47:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 03:59:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 09:01:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 08:40:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/01/2023 08:30:33 PM
- Atomera’s Advanced Materials R&D Provides Specialized Expertise to the CHIPS and Science Act Funded Innovation Hub • Business Wire • 10/17/2023 09:00:00 PM
- Media Alert: Atomera to Present at SISPAD 2023 • Business Wire • 09/20/2023 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2023 08:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:35:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2023 09:35:22 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM